References
- AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert‐Eaton myasthenic syndrome. Muscle Nerve 2001; 24(9)1239–1247
- Batocchi A. P., Evoli A., Di Schino C., Tonali P. Therapeuthic apheresis in myasthenia gravis. Ther. Apher. 2000; 4(4)275–279
- Bruck W., Neubert K., Berger T., Weber J. R. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination‐possible markers for an antibody‐mediated process. Mult. Scler. 2001; 7(3)173–177
- Chia D., Barnett E. V., et al. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol. Clin. Exp. Immunol. 1979; 37: 399–400
- de Andres C., Anaya F., Gimenez‐Roldan S. Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses. Rev. Neurol. 2000; 30(7)601–605
- Hadden R. D., Gregson N. A. Guillain‐Barre syndrome and Campylobacter jejuni infection. Symp. Ser. Soc. Appl. Microbiol. 2001; 30: 145S–154S
- Haupt W. F. Recent advances of therapeutic apheresis in Guillain Barrè syndrome. Ther. Apher. 2000; 4(4)271–274
- Haupt W. F., Birkmann C., van der Ven C., Pawlik J. Apheresis and selective adsorption plus immunoglobulin treatment in Guillain Barrè syndrome. Ther. Apher. 2000; 4(3)198–200
- Haupt W. F., Rosenow F., van der Ven C., Birkman C. Immunoadsorption in Guillain Barrè syndrome and myasthenia gravis. Ther. Apher. 2000; 4(3)195–197
- Hughes R. A., Hadden R. D., Gregson N. A., Smith K. J. Pathogenesis of Guillain‐Barre syndrome. J. Neuroimmunol. 1999; 100(1–2)74–97
- Lindstrom J. An easy for antibodies to human acetylcholine receptor in serum from patient with myastenia gravis. Clin. Immunol. Immunopathol. 1977; 7: 36–43
- Malcheski P. S., Horiuchi T., Usami M., Emura M., Nose J. Blood detoxification by membrane plasma filtration. Int. J. Art. Org. 1986; 9(5)349–354
- Morosetti M., Meloni C., Iani C., Caramia M., Galderisi C., Palombo G., Gallucci M. T., Bernardi G., Casciani C. U. Plasmapheresis in severe forms of myasthenia gravis. Artif. Organs 1998; 22(2)129–134
- Nakaji S., Oka K., Tanihara M., Takakura K., Takamori M. Development of a specific immunoadsorbent containing immobilized synthetic peptide of acetylcholine receptor for treatment of myasthenia gravis. Ther. Apher. 2000; 4(2)124–126
- Nevo Y. Childhood chronic inflammatory demyelinating polyneuropathy. Eur. J. Paediatr. Neurol. 1998; 2(4)169–177
- Palace J., Vincent A., Beeson D. Myasthenia gravis: diagnostic and management dilemmas. Curr. Opin. Neurol. 2001; 14(5)583–589
- Ross E. A., Branham M. L., Tebett I. R. High mass clearance of autoantibodies from a murine model of lupus nephritis by immunoadsorption using star‐configured polyethylene glycols. J. Biomed. Mater. Res. 2001; 55(1)114–120
- Sghirlanzoni A., Pelucchetti D., et al. Myasthenia gravis: prolonged treatment with steroids. Neurology 1984; 34: 170–174
- Steimnam L. Immunotherapy of multiple sclerosis: the end of the beginning. Curr. Opin. Immunol. 2001; 13(5)597–600
- Tagawa, et al. Ability to remove immunoglobulins and anti‐ganglioside antibodies by plasma exchange, DFP and immunoadsorption. J. Neurol. Sci. 1998; 157(1)90–95
- Takahashi I., Sawaishi Y., Takeda O., Enoki M., Takada G. Childhood multiple sclerosis treated with plasmapheresis. Pediatr. Neurol. 1997; 17(1)83–87
- Vedanarayanan V. V., Chaudhry V. Guillain Barrè syndrome: recent advances. Indian J. Pediatr. 2000; 67(9)635–646
- Vincent A., Palace J., Hilton‐Jones D. Myasthenia gravis. Lancet 2001; 357(9274)2122–2128
- Wandinger K. P., Sturzebecher C. S., Bielekova B., et al. Complex immunomodulatory effects of interferon‐beta in multiple sclerosis include the upregulation of T helper 1‐associated marker genes. Ann. Neurol. 2001; 50(3)349–357
- Yamavaki N. Artificial receptors and their clinical applications to blood purification therapy. J. Synt. Org. Chem. 1985; 43: 1024
- Yuki N., Susuki K., Hirata K. Ataxic form of Guillain‐Barr syndrome associated with anti‐GD1b IgG antibody. J. Neurol. Neurosurg. Psychiatry 2000; 69(1)136–137